Latest Breaking News On - Romain de rauville - Page 1 : comparemela.com

Access to CAR-T therapies in Central and Eastern Europe in catch-up mode

Although some countries are moving ahead, the use of CAR-T therapies in the region remains uneven.

Bratislavsky krajSlovak republicCzech republicSofiya gradCastillay leópAdam zamecnikGuenka petrovaMaciej niewadaMatt lakelinMohamad mohtyAndrej vranovskPetr cetkovskNovartis kymriahDepartment of social pharmacyOrganization for economicEuropean commission

IDT Biologika and Exothera Collaborate on Scaling Up Viral Vaccines

Exothera officials say the company has successfully transferred IDT Biologika’s upstream process from small- to large-scale using the NevoLine™ upstream platform developed by Univercells Technologies. NevoLine is an integrated and automated manufacturing solution for the production of viral vaccines, viral vectors, and oncolytic viruses. The platform reportedly reduces the required footprint, infrastructure, and operational costs to achieve scalable production of biologics.

Univercells technologieSimone kardinahlModified vaccinia ankaraRomain de rauville

Genequine Selects Exothera to Support Gene Therapy Manufacturing

Genequine Selects Exothera to Support Gene Therapy Manufacturing
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Gauthier ponceletGenequine biotherapeuticsRomain de rauville

Genequine selects Exothera to support the next stage of its osteoarthritis gene therapy development

Genequine selects Exothera to support the next stage of its osteoarthritis gene therapy development
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Gauthier ponceletGenequine biotherapeutics gmbVp business development at exotheraFlexion therapeutics incRomain de rauvilleManufacturing managerFlexion therapeutics